Cassava Sciences Inc (SAVA)
22.14
-0.02
(-0.09%)
USD |
NASDAQ |
May 01, 14:26
Cassava Sciences Free Cash Flow: -82.44M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -82.44M |
| September 30, 2023 | -81.07M |
| June 30, 2023 | -77.22M |
| March 31, 2023 | -69.88M |
| December 31, 2022 | -80.23M |
| September 30, 2022 | -67.33M |
| June 30, 2022 | -81.43M |
| March 31, 2022 | -74.06M |
| December 31, 2021 | -52.41M |
| September 30, 2021 | -45.50M |
| June 30, 2021 | -10.86M |
| March 31, 2021 | -6.494M |
| December 31, 2020 | -5.382M |
| September 30, 2020 | -4.796M |
| June 30, 2020 | -3.355M |
| March 31, 2020 | -3.104M |
| December 31, 2019 | -2.532M |
| September 30, 2019 | -2.508M |
| June 30, 2019 | -3.214M |
| March 31, 2019 | -3.749M |
| December 31, 2018 | -4.77M |
| September 30, 2018 | -5.642M |
| June 30, 2018 | -6.357M |
| March 31, 2018 | -8.428M |
| December 31, 2017 | -8.237M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.83M |
| June 30, 2017 | -10.54M |
| March 31, 2017 | -10.62M |
| December 31, 2016 | -12.31M |
| September 30, 2016 | -12.83M |
| June 30, 2016 | -12.37M |
| March 31, 2016 | -11.05M |
| December 31, 2015 | -9.248M |
| September 30, 2015 | -8.264M |
| June 30, 2015 | -7.526M |
| March 31, 2015 | -8.169M |
| December 31, 2014 | -9.629M |
| September 30, 2014 | -8.519M |
| June 30, 2014 | -8.666M |
| March 31, 2014 | -7.876M |
| December 31, 2013 | -6.947M |
| September 30, 2013 | -7.347M |
| June 30, 2013 | -6.825M |
| March 31, 2013 | -6.974M |
| December 31, 2012 | -7.171M |
| September 30, 2012 | -6.126M |
| June 30, 2012 | -6.002M |
| March 31, 2012 | -5.599M |
| December 31, 2011 | -0.26M |
| September 30, 2011 | -2.79M |
Free Cash Flow Range, Past 5 Years
-82.44M
Minimum
Dec 2023
-2.508M
Maximum
Sep 2019
-39.67M
Average
-45.50M
Median
Sep 2021
Free Cash Flow Benchmarks
| Amylyx Pharmaceuticals Inc | 10.68M |
| Clearside Biomedical Inc | -19.91M |
| Lantern Pharma Inc | -14.37M |
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.32M |
| Cash from Investing (Quarterly) | -0.041M |
| Cash from Financing (Quarterly) | 1.143M |
| Free Cash Flow Per Share (Quarterly) | -0.5299 |
| Free Cash Flow Yield | -8.88% |